Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer

Affiliations

• ¹ Department of Urology, Wan Fang Hospital, Taipei Medical University, Taipei, 11696, Taiwan.
• ² Department of Urology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 11031, Taiwan.
• ³ TMU Research Center of Urology and Kidney, Taipei Medical University, Taipei, 11031, Taiwan.
• ⁴ International PhD Program in Medicine, College of Medicine, Taipei Medical University, Taipei, 11031, Taiwan.
• ⁵ Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, 11031, Taiwan.
• ⁶ Genomics Research Center, Academia Sinica, Taipei, 11529, Taiwan.
• ⁷ Department of Pathology, Duke University Medical Center, Durham, NC, 27710, USA.
• ⁸ Department of Pathology, Wan Fang Hospital, Taipei Medical University, Taipei, 11696, Taiwan. 1047@tmu.edu.tw.
• ⁹ Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 11031, Taiwan. 1047@tmu.edu.tw.
• ¹⁰ Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, 11031, Taiwan. liuy@tmu.edu.tw.
• ¹¹ TMU Research Ceśnter of Cancer Translational Medicine, Taipei Medical University, Taipei, 11031, Taiwan. liuy@tmu.edu.tw.